OBF1 and Oct factors control the germinal center transcriptional program.


Journal

Blood
ISSN: 1528-0020
Titre abrégé: Blood
Pays: United States
ID NLM: 7603509

Informations de publication

Date de publication:
27 05 2021
Historique:
received: 02 12 2020
accepted: 29 12 2020
pubmed: 30 1 2021
medline: 15 12 2021
entrez: 29 1 2021
Statut: ppublish

Résumé

OBF1 is a specific coactivator of the POU family transcription factors OCT1 and OCT2. OBF1 and OCT2 are B cell-specific and indispensable for germinal center (GC) formation, but their mechanism of action is unclear. Here, we show by chromatin immunoprecipitation-sequencing that OBF1 extensively colocalizes with OCT1 and OCT2. We found that these factors also often colocalize with transcription factors of the ETS family. Furthermore, we showed that OBF1, OCT2, and OCT1 bind widely to the promoters or enhancers of genes involved in GC formation in mouse and human GC B cells. Short hairpin RNA knockdown experiments demonstrated that OCT1, OCT2, and OBF1 regulate each other and are essential for proliferation of GC-derived lymphoma cell lines. OBF1 downregulation disrupts the GC transcriptional program: genes involved in GC maintenance, such as BCL6, are downregulated, whereas genes related to exit from the GC program, such as IRF4, are upregulated. Ectopic expression of BCL6 does not restore the proliferation of GC-derived lymphoma cells depleted of OBF1 unless IRF4 is also depleted, indicating that OBF1 controls an essential regulatory node in GC differentiation.

Identifiants

pubmed: 33512466
pii: S0006-4971(21)00180-4
doi: 10.1182/blood.2020010175
doi:

Substances chimiques

Ets1 protein, mouse 0
Lipopolysaccharides 0
Octamer Transcription Factor-1 0
Octamer Transcription Factor-2 0
POU2AF1 protein, human 0
POU2F1 protein, human 0
POU2F2 protein, human 0
Pou2af1 protein, mouse 0
Pou2f1 protein, mouse 0
Pou2f2 protein, mouse 0
Proto-Oncogene Protein c-ets-1 0
RNA, Small Interfering 0
Recombinant Proteins 0
Trans-Activators 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2920-2934

Commentaires et corrections

Type : CommentIn

Informations de copyright

© 2021 by The American Society of Hematology.

Auteurs

Shuang Song (S)

Friedrich Miescher Institute for Biomedical Research, Basel, Switzerland.
Faculty of Sciences and.

Chun Cao (C)

Friedrich Miescher Institute for Biomedical Research, Basel, Switzerland.

Mohamed-Amin Choukrallah (MA)

Friedrich Miescher Institute for Biomedical Research, Basel, Switzerland.

Fengyuan Tang (F)

Department of Biomedicine, University of Basel, Basel, Switzerland.

Gerhard Christofori (G)

Department of Biomedicine, University of Basel, Basel, Switzerland.

Hubertus Kohler (H)

Friedrich Miescher Institute for Biomedical Research, Basel, Switzerland.

Fabian Wu (F)

Novartis Institutes for Biomedical Research, Basel, Switzerland.

Barna D Fodor (BD)

Novartis Institutes for Biomedical Research, Basel, Switzerland.

Mathias Frederiksen (M)

Novartis Institutes for Biomedical Research, Basel, Switzerland.

Simon N Willis (SN)

The Walter & Eliza Hall Institute of Medical Research, Parkville, VIC, Australia.
Department of Medical Biology, University of Melbourne, Parkville, VIC, Australia.

Jacob T Jackson (JT)

The Walter & Eliza Hall Institute of Medical Research, Parkville, VIC, Australia.
Department of Medical Biology, University of Melbourne, Parkville, VIC, Australia.

Stephen L Nutt (SL)

The Walter & Eliza Hall Institute of Medical Research, Parkville, VIC, Australia.
Department of Medical Biology, University of Melbourne, Parkville, VIC, Australia.

Stefan Dirnhofer (S)

University Hospital Basel, Basel, Switzerland; and.

Michael B Stadler (MB)

Friedrich Miescher Institute for Biomedical Research, Basel, Switzerland.
Faculty of Sciences and.
Swiss Institute of Bioinformatics, Basel, Switzerland.

Patrick Matthias (P)

Friedrich Miescher Institute for Biomedical Research, Basel, Switzerland.
Faculty of Sciences and.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH